|
PSPC1 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.602450E-03 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.658100E-03 |
| Normal-vs-Stage2 |
4.635100E-03 |
| Normal-vs-Stage3 |
1.390080E-02 |
| Normal-vs-Stage4 |
3.044200E-02 |
| Stage1-vs-Stage2 |
6.871800E-01 |
| Stage1-vs-Stage3 |
9.355000E-01 |
| Stage1-vs-Stage4 |
8.187000E-01 |
| Stage2-vs-Stage3 |
6.749800E-01 |
| Stage2-vs-Stage4 |
9.494600E-01 |
| Stage3-vs-Stage4 |
7.944400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
9.228400E-04 |
| Normal-vs-AfricanAmerican |
1.804240E-02 |
| Normal-vs-Asian |
9.008200E-02 |
| Caucasian-vs-AfricanAmerican |
4.830600E-01 |
| Caucasian-vs-Asian |
9.795400E-01 |
| AfricanAmerican-vs-Asian |
8.002000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.844800E-04 |
| Normal-vs-Female |
4.175500E-02 |
| Male-vs-Female |
1.237650E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
1.942030E-02 |
| Normal-vs-Extreme_Weight |
1.583630E-03 |
| Normal-vs-Obese |
2.465800E-02 |
| Normal-vs-Extreme_Obese |
7.963300E-04 |
| Normal_Weight-vs-Extreme_Weight |
5.826800E-01 |
| Normal_Weight-vs-Obese |
6.695000E-01 |
| Normal_Weight-vs-Extreme_Obese |
1.607970E-01 |
| Extreme_Weight-vs-Obese |
2.503400E-01 |
| Extreme_Weight-vs-Extreme_Obese |
2.141000E-01 |
| Obese-vs-Extreme_Obese |
6.609800E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
6.987700E-02 |
| Normal-vs-Age(41-60Yrs) |
8.050500E-02 |
| Normal-vs-Age(61-80Yrs) |
1.69493999999659E-05 |
| Normal-vs-Age(81-100Yrs) |
7.393300E-04 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.720600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.295600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.556200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.382630E-03 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.538100E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.360400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
8.060700E-03 |
| Normal-VS-Type2 PRCC |
1.89774000000087E-05 |
| Normal-VS-KIRP CIMP |
6.983900E-03 |
| Normal-VS-Unclassified PRCC |
2.592200E-02 |
| Type1 PRCC-VS-Type2 PRCC |
2.590400E-02 |
| Type1 PRCC-VS-KIRP CIMP |
3.165200E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
8.863000E-01 |
| Type2 PRCC-VS-KIRP CIMP |
9.595800E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
6.813600E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
2.743000E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
7.89180000000389E-05 |
| Normal-vs-N1 |
5.877800E-01 |
| Normal-vs-N2 |
1.376760E-03 |
| N0-vs-N1 |
8.021300E-03 |
| N0-vs-N2 |
9.616000E-02 |
| N1-vs-N2 |
3.021800E-02 |
|
|
